Sep 12, 2022 / 02:30PM GMT
Unidentified Analyst -
So welcome, everyone, and a warm welcome to our fireside chat today hosted by the MS Global Healthcare Conference. I'm [Aisha Noor] from the European MedTech team here at Morgan Stanley, and I'm very pleased to be joined today by Thierry Bernard, CEO of QIAGEN. This session will take approximately 30 minutes, and you can participate with your questions for this session by just raising your hand, and I'll let you speak. With that, welcome Thierry, and thank you for joining us today.
Questions and Answers:
Unidentified Analyst -Maybe if we start off with your 5 pillars of growth, starting off with sample tech. I mean, growth in your sample tech business, especially even in the non-COVID segment, was relatively strong in the first half. How much of that would you attribute to market recovery versus market share gains? And how sustainable do you think that is going forward?
Thierry Bernard - Qiagen N.V. - CEO, MD & Member of Management Board
Thanks, and thanks for your attention and for coming this